講演情報
[HT-06-3]Network Hyperexcitability in Alzheimers Disease: An Early Intervention Opportunity
Keith Vossel (Professor and Director of the Alzheimer's Disease Research Center, UCLA)
Dr. Keith Vossel is the Michael M. Minchin, Jr., President, J.D. French Alzheimer’s Foundation Endowed Chair, Director of the Alzheimer’s Disease Research Center, and Professor of Neurology at UCLA. He leads a multidisciplinary center dedicated to advancing equity in dementia recognition and care while developing innovative therapies through outreach, neuroimaging, neurophysiology, genetics, clinical trials, and clinical programs.
Dr. Vossel received a master’s degree in biomedical engineering and medical degree with highest honors from the University of Tennessee. He completed his neurology residency at Harvard Massachusetts General Hospital, serving as chief resident, followed by a fellowship in behavioral neurology and dementia research at UCSF and the Gladstone Institutes.
Dr. Vossel investigates Alzheimer's disease and related dementias, focusing on brain rhythm abnormalities and translational therapies. His groundbreaking research on subclinical epileptic activity in Alzheimer’s disease has inspired global investigations into this phenomenon across diverse populations.
Dr. Vossel has been honored by many awards including the John Douglas French Alzheimer's Distinguished Research Scholar Award, the Alzheimer’s Association’s Part the Cloud Translational Research Award, the Bernese Epilepsy Award from the University of Bern, and the Outstanding Health Care Innovator Award from the Los Angeles Business Journal.
Dr. Vossel received a master’s degree in biomedical engineering and medical degree with highest honors from the University of Tennessee. He completed his neurology residency at Harvard Massachusetts General Hospital, serving as chief resident, followed by a fellowship in behavioral neurology and dementia research at UCSF and the Gladstone Institutes.
Dr. Vossel investigates Alzheimer's disease and related dementias, focusing on brain rhythm abnormalities and translational therapies. His groundbreaking research on subclinical epileptic activity in Alzheimer’s disease has inspired global investigations into this phenomenon across diverse populations.
Dr. Vossel has been honored by many awards including the John Douglas French Alzheimer's Distinguished Research Scholar Award, the Alzheimer’s Association’s Part the Cloud Translational Research Award, the Bernese Epilepsy Award from the University of Bern, and the Outstanding Health Care Innovator Award from the Los Angeles Business Journal.